COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12+ years - PI for GB
COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) ready for use, children 5 to 11 years - PI for GB
COMIRNATY Omicron XBB.1.5 3 micrograms/dose concentrate for dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, 6 months to 4 years - PI for GB
COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12+ years - PI for NI
COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) ready for use, children 5 to 11 years - PI for NI
COMIRNATY Omicron XBB.1.5 3 micrograms/dose concentrate for dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, 6 months to 4 years - PI for NI
COMIRNATY Original/Omicron BA.4-5 (tozinameran / famtozinameran) (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12+ years - PI for GB
COMIRNATY Original/Omicron BA.1 (tozinameran / riltozinameran) (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12+ years - PI for GB
COMIRNATY (tozinameran) 30 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, 12+ years - PI for GB
COMIRNATY (tozinameran) 10 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, children 5 to 11 years - PI for GB
COMIRNATY (tozinameran) 3 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified), dilute before use, 6 months to 4 years - PI for GB
COMIRNATY Original/Omicron BA.4-5 (tozinameran / famtozinameran) (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12 + years - PI for NI
COMIRNATY Original/Omicron BA.1 (tozinameran / riltozinameran) (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12+ years - PI for NI
COMIRNATY (tozinameran) 30 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, 12+ years - PI for NI
COMIRNATY (tozinameran) 10 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, children 5 to 11 years - PI for NI
COMIRNATY (tozinameran) 3 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified), dilute before use, 6 months to 4 years - PI – NI
PP-CMR-GBR-0423 September 2023